NCODA Logo

Medically-Integrated Oncology Pharmacy Residency Program

An Innovative & Direct Path To A Successful Career in Oncology Pharmacy

The NCODA Medically-Integrated Oncology Pharmacy (MIOP) Residency Program provides new pharmacy graduates and practicing pharmacists an exclusive opportunity to engage in a comprehensive 1-year training program at a medically integrated pharmacy designed to prepare participants for a successful career in oncology pharmacy. NCODA is working with cancer centers throughout the United States to provide the framework and accreditation for this residency program.

Resources for Medically Integrated Oncology Teams

Florida Cancer Specialists & Research Institute

OUR PURPOSE

To help participants gain and develop comprehensive skills and knowledge to treat cancer patients with the highest level of care. Upon completion of this residency program, graduates will be highly committed, lifelong learners that are able to adapt to various oncology practice settings. Graduates will also become empowered healthcare leaders focused on innovating the continuity of cancer care.

WHAT IS A MEDICALLY-INTEGRATED PHARMACY?

A dispensing pharmacy within an oncology center of excellence that promotes a patient-centered, multidisciplinary team approach. It is an outcome-based collaborative and comprehensive model that involves oncology healthcare professionals and other stakeholders who focus on the continuity of coordinated quality care and therapies for cancer patients.

PARTICIPATING PROGRAMS

  • Florida Cancer Specialists & Research Institute (Fort Myers, FL)
  • Texas Oncology (Dallas/Fort Worth, TX)
  • Tennessee Oncology (Nashville, TN)

*Additional programs to be announced. One resident will be selected per practice site.

“My experience in the MIOP residency at Florida Cancer Specialists & Research Institute has been incredibly rewarding. Everyone here is supportive and approachable, creating a welcoming and collaborative environment. Throughout these last few months, my knowledge of oncology has grown significantly, and I have been able to immerse myself in the field in ways that have completely changed my perspective on cancer care. The opportunities for growth and networking offered by this residency are unmatched, and I would highly recommend it to any pharmacist interested in pursuing a career in oncology pharmacy!”

Gabriela Aponte Melendez, PharmD

MIOP Pharmacy Resident 2024-2025 | Florida Cancer Specialists & Research Institute

future leaders in pharmacy

PROGRAM OVERVIEW

The MIOP Residency Program includes 4 specific rotations:

    • Oral Outpatient Oncology Practice (5 Months)
    • IV/Infusion Oncology Practice (5 Months)
    • Pharmacy Business/Leadership (2 Months)
    • Research (12 Months |Longitudinal | Finding presented at NCODA Spring Forum)

The goals and competencies of each rotation are developed by the rotation preceptors and approved by NCODA’s Residency Review Committee. The activities and projects that each resident is involved in per rotation will be determined by the Rotation Preceptor and resident prior to the rotation start date, in accordance with NCODA’s MIOP Residency Manual.

Treatment kits for Medically Integrated Oncology Teams

Texas Oncology

“Since beginning my NCODA MIOP Pharmacy Residency with Park Pharmacy at Tennessee Oncology, I have learned an abundance of information regarding oral oncolytic treatment options for cancer patients and a pharmacist’s role in dispensing these orals to patients in addition to the importance of managing medication adherence. I’m now a practicing, licensed pharmacist and gaining valuable knowledge with IV chemotherapy regimens, presenting on disease state topic discussions, and completing assignments/projects that will not only help Park Pharmacy but will continue to help me grow as a new pharmacist both professionally and personally. I look forward to what else my residency has to offer me going forward.”

Joy C. Morrow, PharmD

MIOP Pharmacy Resident 2024-2025 | Tennessee Oncology

Program Benefits

 

Candidates

  • Direct path to a career in oncology clinical pharmacy
  • Innovative streamlined training in Medically-Integrated Oncology Pharmacy
  • Comprehensive oncology education and training at top cancer centers
  • Flexibility of tailored rotation opportunities
  • Publication and presentation opportunities
  • Network at oncology conferences
  • Collaborate with NCODA’s network of practices
  • Competitive salary

CANCER CENTERS

  • Establish an accredited residency program at cancer center
  • Custom tailored residency accreditation from NCODA
  • Access to curated residency applicant pool
  • Expand research opportunities
  • Leadership development pipeline (resident –> future practice leader)
  • Collaborate with NCODA practices on residency opportunities

Application Criteria

Completion of pharmacy degree (ACPE-accredited pharmacy school)

Eligible to work in the United States

Curriculum vitae

Official transcript(s)

Letter of intent

2 letter of recommendation contacts

Preferred Experience & Qualifications

Collaborative

Strong verbal and written communication skills

Strong interpersonal skills

Proficient with Microsoft Office

Self-starter and able to work independently with minimal supervision

Eligible for current state licensure based on residency location

Residency Timeline

Application Opens: 11/01/24

Application Due: 01/31/25

Interview Period: 11/1/24 – 02/28/25

Selection: 03/01/25 – 04/05/25

Start Date: 06/24/25 – 07/08/25

$32 Application Fee

*Dates are subject to change per program need.

“My time at Texas Oncology’s MIOP Residency through NCODA has been incredible and full of rewarding experiences. I appreciate the hands-on approach for residency and cannot imagine a better experience for those wanting to go into Oncology Pharmacy. Each project offered to me is meaningful and I can proudly say I am passionate about every one that I have done”

Nathan Uk, PharmD

MIOP Pharmacy Resident 2024-2025 | Texas Oncology

MIOP Residency Program is led by:

Cooper Bailey, PharmD
Manager of Program Development and Strategy | MIOP Residency Coordinator

Complete the form below to start the application process for the MIOP Residency Program.

*All applications are reviewed by NCODA Residency Review Committee. Candidates selected for the next step will be contacted by February 28, 2025 to continue the residency application process. Applicants can address their LOI to all the practices or address it to the practice they would like to apply for.

Address(Required)
*College of Pharmacy(Required)
*Have you applied to any other residency program? If yes, please state program name(s).(Required)

*Upload Your CV
Max. file size: 50 MB.
*Upload Your Unofficial Transcript(s)
Max. file size: 50 MB.
*Upload Your Letter of Intent (All Programs)
Max. file size: 50 MB.
Contact Information for Letter of Reference
(Minimum 2, Max 3)
Letter of Recommendation
Letter of Recommendation

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

contact@ncoda.org

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA Logo

NCODA is a 501(c)(3) Organization